Skip to main content

Month: August 2025

Faraday Future Reports Financial Results for Second Quarter 2025

Faraday Future Reports Financial Results for Second Quarter 2025Faraday Future Reports Financial Results for Second Quarter 2025Q2 adjusted operating loss stood at approximately $27.4 million, with a monthly average of $9 million during this quarter; Quarter-end cash position reached an 18-month high; Operating efficiency and cost control continued to strengthen. Officially added to the Russell 3000 Index—a key milestone that enhances visibility and credibility among institutional investors, analysts, and the broader market. Top-tier international fund managers continued to increase their holdings in FFAI. Vanguard and BlackRock both increased their holdings in FFAI by over 500%, compared with Q4 2024. Announced that Mariah Carey, the best-selling female artist of all time and global top music legend, will become the next owner...

Continue reading

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations Her appointment brings over 30 years of strategic, commercial, and operational expertise in the pharmaceutical and broader healthcare industry, with a focus on digital innovationSAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD) today announced the election of Nicole Mowad-Nassar to its board of directors, effective August 15, 2025. The company also announced that board member Rich Sulpizio is thanked for two decades of contributions to Resmed, and will retire from the board, not standing for reelection at the 2025 Annual Meeting of Stockholders, scheduled for November 19, 2025. Nicole Mowad-Nassar currently serves as President of Specialty and U.S. Therapeutics Operations at AbbVie. She leads a $6...

Continue reading

Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma

First T cell therapy for a solid tumor cancer and first treatment option approved in Canada for advanced melanoma after anti-PD-1 and targeted therapy SAN CARLOS, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced Health Canada has issued a Notice of Compliance with Conditions (NOC/c) for Amtagvi® (lifileucel), a tumor-derived autologous T cell immunotherapy. Amtagvi is indicated for the treatment of adult patients with unresectable or metastatic melanoma that has progressed on or after at least one prior systemic therapy including a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor...

Continue reading

TILT Holdings Announces Closing on Sale of Massachusetts Dispensaries to In Good Health

SCOTTSDALE, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (Cboe CA:TILT) (OTCID: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, announced today the closing of the sale of two of its Massachusetts dispensaries to In Good Health. The definitive agreement for this transaction was previously announced on February 3, 2025. Simultaneously, with the closing, the parties entered into an amendment adjusting the purchase price to $1.75 million. The retail transaction is part of TILT’s overall strategic alternatives review. Under the terms of the transaction for the two stores, In Good Health will operate the Taunton location going forward and the Brockton dispensary was shut down. Highgate...

Continue reading

Fabrinet Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Record Fourth Quarter Revenue Exceeds Guidance Range Record Fiscal Year 2025 Revenue Increases 19% Year-over-yearBANGKOK, Aug. 18, 2025 (GLOBE NEWSWIRE) — Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced its financial results for its fourth quarter and fiscal year ended June 27, 2025. Seamus Grady, Chief Executive Officer of Fabrinet, said, “Our fourth quarter was exceptional, capping off a remarkable year with strong momentum. We achieved record quarterly revenue of $910 million, exceeding our guidance range. Through excellent execution, our non-GAAP EPS also reached a new all-time high. For all of fiscal year 2025, we achieved record revenue of $3.4 billion,...

Continue reading

First Advantage Releases Fourth Annual Sustainability Impact Report

The 2024 Report Highlights Progress in Environmental, Community, and Governance Priorities Amid Transformational Growth ATLANTA, Aug. 18, 2025 (GLOBE NEWSWIRE) — First Advantage Corporation (NASDAQ:FA), a leading provider of global software and data in the HR technology industry, today announced the release of its 2024 Sustainability Impact Report. The fourth annual report outlines the company’s continued commitment to responsible business practices and transparent progress across key environmental, community, and governance priorities. The 2024 report records a milestone year for First Advantage, marked by its acquisition of Sterling Check Corp., that closed on Oct. 31, 2024. Throughout this period of growth, First Advantage reaffirmed its sustainability focus areas: people and community, environment and climate, governance and...

Continue reading

$10,000 in Cash Up for Grabs in F&M Bank’s “The Great Briefcase Hunt”

Six clues. One hidden briefcase. A community adventure with big rewardsARCHBOLD, Ohio, Aug. 18, 2025 (GLOBE NEWSWIRE) — F&M Bank (“F&M”), an Archbold, Ohio-based bank owned by Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO), is inviting the community to put on their detective hats for a high-stakes summer challenge, $5,000 for a lucky hunter and $5,000 for a local charity. The Great Briefcase Hunt kicked off Monday, August 18, 2025, and dares residents across the F&M footprint to follow a series of weekly clues leading to a hidden briefcase in a local park. “It’s time to join the hunt,” said Amy Cover, Chief Marketing Officer at F&M Bank. “We are creating an adventure that sparks excitement, brings people outside, connects neighbors, and delivers a huge ‘wow’ moment when that briefcase is finally found....

Continue reading

TOFUTTI ANNOUNCES RESULTS FOR THE THIRTEEN AND TWENTY-SIX WEEKS ENDED JUNE 28, 2025

Edison, New Jersey, Aug. 18, 2025 (GLOBE NEWSWIRE) — TOFUTTI BRANDS INC. (OTCQB Symbol: TOFB) issued its results for the thirteen and twenty-six weeks ended June 28, 2025 and June 29, 2024 today. Tofutti Brands reported net sales for the thirteen weeks ended June 28, 2025 decreased by $254,000, or 11%, from net sales of $2,283,000 for the thirteen weeks ended June 29, 2024 to $2,029,000 for the thirteen weeks ended June 28, 2025. Sales of our vegan cheese products decreased to $1,708,000 in the thirteen weeks ended June 28, 2025 from $1,926,000 in the thirteen weeks ended June 29, 2024, due to increased competition in the vegan cheese category. Sales of our frozen dessert products decreased to $321,000 in the thirteen weeks ended June 28, 2025 from $357,000 for the thirteen weeks ended June 29, 2024. Our sales were also negatively...

Continue reading

HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results

MIRAMAR, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its second quarter ended June 30, 2025.  On May 15, 2025, the Company closed an equity offering with gross proceeds of $5.0 million with a single institutional investor. Dr. Hing Wong, Founder and CEO, stated, “We are pleased to have completed a successful $5.0 million equity offering in a challenging market without using a highly structured deal. This funding will be used to open clinical sites for our Phase 1 clinical trial to evaluate HCW9302 in an...

Continue reading

Terra Balcanica Intersects Gold Mineralization Over 72 m and Starts Drill Program At Brezani Target in Bosnia

Vancouver, British Columbia, Aug. 18, 2025 (GLOBE NEWSWIRE) — Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA: UB1) is pleased to announce an expansion of the surface gold skarn system at Brezani and the start of the Phase III drill program at its Viogor-Zanik project, Bosnia and Herzegovina. HighlightsThe Brezani drillhole BRE23001 located 125 m SSW of the maiden Brezani drillhole intercepted 0.27 g/t Au over 72.3 m including 0.62 g/t Au over 7.5 m. Additionally, two antimony veined zones, 1.5 and 0.5 m wide were intersected, respectively (Figure 2);The drillhole BRE23002 located 145 m northwest of BRE23001 intercepted 1.51 Zn% over 6 m including 0.54% Sb over 1.65 m as well as 0.6 g/t Au over 2.85 m;The drillhole BRE23003 located 77 m southeast of the maiden Brezani drillhole encountered 0.19%...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.